Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Researchers found markers that can tell if hair has been bleached, which could improve hair test accuracy.

HFMs can help study hair growth and test potential hair growth drugs.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Diagnosing simple-virilizing congenital adrenal hyperplasia can be difficult and requires thorough testing and expert advice.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Finasteride affects urinary steroid profiles and can potentially hide steroid abuse in sports drug testing.

A young woman's symptoms suggested PCOS, but tests and surgery confirmed and treated a rare ovarian tumor, resolving her condition.

Human hair follicle organ culture is a useful model for hair research with potential for studying hair biology and testing treatments.

Vitiligo is linked to autoimmune diseases and hearing issues, so hearing tests are recommended for patients.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Zebrafish larvae are used to study and find treatments for ear cell damage because they are easier to observe and test than mammals.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

An 11-year-old Greek girl was diagnosed with a rare genetic disorder, highlighting the importance of genetic testing and family history.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Nonclassic adrenal hyperplasia is a genetic condition that can cause early puberty and fertility problems, treated with specific steroids.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

Scalp massage reduces stress, increases relaxation, and improves blood circulation.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Spironolactone is a safe and effective treatment for reducing excessive hair growth in women.

DHT in the human prostate is produced through multiple pathways, not just from testosterone.

Spironolactone reduced hair thickness and some testosterone levels in women with excessive hair growth.

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.

Human leukocytes and beard hair follicle cells have internal daily clocks, and PER1 and PER3 genes may indicate individual circadian rhythms.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Men with male pattern hair loss have different levels of certain hormones compared to men without hair loss.

Dihydrotestosterone specifically binds to hamster sebaceous glands, with a higher affinity than testosterone.